Bivin & Associates’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$4K Hold
800
﹤0.01% 198
2022
Q1
$7K Buy
800
+100
+14% +$875 0.01% 192
2021
Q4
$10K Buy
+700
New +$10K 0.01% 186